Litcius/Paper detail

Validation of the GeneXpert Xpress SARS-CoV-2 PCR assay using saliva as biological specimen

Sara Nunes Vaz, Daniele Souza de Santana, Eduardo Martins Netto, Wei‐Kung Wang, Carlos Brites

2021The Brazilian Journal of Infectious Diseases13 citationsDOIOpen Access PDF

Abstract

In the pandemic, rapid and accurate detection of SARS-CoV-2 is crucial in controlling the outbreak. Recent studies have shown a high detection rate using saliva/oral fluids as specimens for laboratory detection of the virus. We intended to evaluate the test performance of the Xpert Xpress SARS-CoV-2 cartridge assay in comparison to a conventional qRT-PCR testing, using saliva as biological specimen. Forty saliva samples from symptomatic participants were collected. Conventional qRT-PCR was performed for amplification of E and RdRp genes and the Xpert Xpress SARS-CoV-2 assay amplified E and N2 genes. In the conventional assay, the median cycle threshold value of the E gene was 34.9, and of the RdRp gene was 38.3. In the Xpert Xpress assay, the median cycle threshold value of the E gene was 29.7, and of the N2 gene was 31.6. These results can allow a broaden use of molecular tests for management of COVID-19 pandemic, especially in resources-limited settings.

Topics & Concepts

SalivaGeneXpert MTB/RIFCoronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineBiologySputumInternal medicinePathologyTuberculosisDiseaseInfectious disease (medical specialty)SARS-CoV-2 detection and testingAdvanced biosensing and bioanalysis techniquesSARS-CoV-2 and COVID-19 Research
Validation of the GeneXpert Xpress SARS-CoV-2 PCR assay using saliva as biological specimen | Litcius